Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cardiovascular Disorders

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Recurrent pulseless electrical activity in a patient with coronary vasospasm and supravalvular aortic stenosis: a case report

  • Achim Lother1Email author,
  • Friedhelm Beyersdorf2,
  • Hans H. Osterhues3,
  • Christoph Bode1 and
  • Tobias Wengenmayer1
BMC Cardiovascular DisordersBMC series – open, inclusive and trusted201616:100

https://doi.org/10.1186/s12872-016-0284-5

Received: 29 January 2016

Accepted: 14 May 2016

Published: 23 May 2016

Abstract

Background

Pulseless electrical activity cardiac arrest is associated with poor outcomes and the identification of potentially reversible reasons for cardiac arrest is fundamental.

Case presentation

We describe the case of a 46-year-old male with the rare coincidental finding of supravalvular aortic stenosis and coronary vasospasm leading to recurrent pulseless electrical activity cardiac arrest. Extracorporeal life support was successfully applied for hemodynamic stabilization. Supravalvular aorticstenosis underwent surgical repair. The patient survived five time resuscitation and was discharged after full neurological recovery.

Conclusions

Coronary vasospasm and supravalvular aortic stenosis are rare but potentially reversible causes of pulseless electrical activity cardiac arrest. Extracorporeal life support allows accurate diagnostic and possibly therapy even of uncommon reasons for cardiac arrest.

Keywords

Pulseless electrical activityCardiac arrestCoronary vasospasmSupravalvular aortic stenosisECLS

Background

Cardiac arrest due to pulseless electrical activity (PEA) is associated with poor survival and neurological outcome when compared to a shockable rhythm [1, 2]. To provide successful resuscitation it is fundamental to identify potentially reversible causes for cardiac arrest. The reasons for PEA are considered to be more often non-cardiac including hyperkalemia, hypoglycemia, bleeding or hypovolemia, pulmonary embolism, pneumothorax and cardiac tamponade [24]. This is reflected by current treatment guidelines that recommend the use of laboratory testing or ultrasound during resuscitation [3]. However, cardiac disease needs to be considered as an alternative cause of refractory PEA. Extracorporeal cardiac life support is more and more commonly available and can be applied to allow diagnostic and treatment of potentially reversible causes [3]. These include also uncommon findings that might be missed by routine measures during resuscitation.

We describe here for the first time the case of a patient with the rare coincident finding of coronary vasospasm and supravalvular aortic stenosis leading to recurrent pulseless electrical activity cardiac arrests.

Case presentation

A 46-year-old male was successfully resuscitated for out-of-hospital cardiac arrest due to ventricular fibrillation (Fig. 1). Coronary angiography immediately after admission to the county hospital revealed coronary vasospasm but no coronary artery disease (Fig. 2a). After intracoronary administration of glycerol trinitrate the coronary system exhibited regular flow without any relevant stenosis (Fig. 2b). Pulmonary embolism, aortic dissection and other potentially reversible causes were ruled out by computer-assisted tomography (CT) of the chest and lab-testing. Mild therapeutic hypothermia was established for 24 h. For aspiration pneumonia he was treated with ampicillin and sulbactam.
Fig. 1

Time course. Schematic representation of relevant events. For cardiac arrests initial heart rhythm and time to return of spontaneous circulation are given. vv-ECMO, veno-venous extracorporeal membrane oxygenation; vva-ECMO, veno-veno-arterial extracorporeal membrane oxygenation; PEA, pulseless electrical activity; VF, ventricular fibrillation; ROSC, return of spontaneous circulation

Fig. 2

Coronary vasospasm and supravalvular aortic stenosis leading to pulseless electrical activity cardiac arrest. Coronary angiography of the right coronary artery revealing coronary vasospasm (a) that was relieved by application of glycerol trinitrate (b). ECG recording showing marked intraventricular block during pulseless electrical activity cardiac arrest (c) and a restored QRS (d) after vasodilatory therapy. 3D reconstruction of computer-assisted tomography (e) displaying the supravalvular aortic stenosis (black arrow) and double lumen ECMO cannula (white arrow). Ao, Aorta; LV, left ventricle; RA, right atrium

Because of the development of a severe acute respiratory distress syndrome five days after admission our ECMO team established a veno-venous extra-corporeal membrane oxygenation (vvECMO) system using a 31 Fr bi-caval cannula and transferred the patient to our center (Fig. 1). Another CT of the chest showed progressive bi-pulmonary infiltration but no pulmonary embolism. Subsequently sufficient oxygenation was delivered by combined ECMO treatment and lung protective ventilation.

During his stay in the intensive care unit the patient underwent recurrent episodes of cardiac arrest with pulseless electrical activity (PEA, Fig. 1, Fig. 2c) that were not associated with hypoxemia as he was on full ECMO support. There was no evidence for other causes for PEA like tension pneumothorax or embolism in the bedside ultrasonography and echocardiography. Disturbances in electrolytes could be ruled out be point-of-care testing. As we could not reach a return of spontaneous circulation after 15 min of resuscitation we successfully modified the established vvECMO to a veno-veno-arterial ECMO system by introduction of a 17 Fr delivering cannula into the right femoral artery in order to provide extracorporeal life support (ECLS). This procedure could be performed within 15 min without complications under ongoing CPR. During the following episode PEA was successfully terminated when coronary vasospasm was relieved by i.v. administration of glycerol trinitrate and verapamil while circulation was maintained by ECLS (Fig. 1, Fig. 2d). In total, the patient had experienced five episodes of resuscitation till then. A combined long-acting nitrate and calcium channel blocker vasodilatory therapy was established and successfully prevented further events. ECMO therapy could be stopped 14 days after implantation, weaning from mechanical ventilation was successful after 35 days.

The patient has no family history of cardiac death. He underwent patch-repair for supravalvular aortic stenosis during childhood. On day 6 transthoracic and transesophageal echocardiography revealed a remaining supravalvular aortic stenosis (Vmax 4 m/s, mean pressure gradient 37 mmHg) that was confirmed by CT (Fig.1e, Additional file 1: Video S1). Older medical records showed, that the re-stenosis had been already detected during a rehabilitation exam 20 years ago but did not cause any symptoms. Since hemodynamics remained stable after initiation of vasodilatory therapy surgical repair was postponed until respiratory recovery. The stenosis was successfully relieved by supracoronary ascending aortic replacement on day 44 (Fig. 1).

The patient had full neurological recovery and was discharged to follow-up treatment. A cardiac defibrillator was implanted for secondary prevention of the initial VF.

Discussion

We report a case of recurrent cardiac arrests due to coronary vasospasm and supravalvular aortic stenosis.

The patient survived five episodes of cardiac arrest, four of them with PEA which is an uncommon complication of vasospastic angina. Patients with vasospastic angina pectoris are at higher risk of sudden cardiac death and most often cardiac arrest occurs due to tachycardic ventricular arrhythmia [5]. Nevertheless, as reported in this case, presentation might be different. There are only few previous reports of PEA associated with coronary vasospasm [58], one of them describing recurrent cardiac arrests [6]. The patient described in this case had a supravalvular aortic stenosis which might have a) aggravated low cardiac output during coronary vasospasm and b) triggered coronary vasospasm due to elevated pressures in the aortic bulbus. Supravalvular aortic stenosis is rare in general population but frequent in Williams-Beuren syndrome, a genetic disorder that is associated with an increased rate of cardiovascular events and death [9]. We did not find one of the known Williams-Beuren mutations or other syndromic presentation in this patient.

Veno-arterial ECMO is considered as the preferred method for extracorporeal life support to allow further diagnosis and therapeutic measures when standard life support fails to achieve ROSC [3]. Percutaneous cannulation can be performed fast and with a low rate of complications in the intensive care unit or the cath lab by experienced teams [10]. In this case veno-veno-arterial ECMO was applied to treat concurrent ARDS and cardiac arrests.

Conclusion

In conclusion, the coincidence of coronary vasospasm and supravalvular aortic stenosis lead to recurrent pulseless electrical activity cardiac arrest in this case. Unusual causes for refractory cardiac arrest should be considered during and after resuscitation. Extracorporeal life support provides the opportunity for accurate diagnostic and therapy when routine diagnostic measures are not sufficient.

Abbreviations

CT, computer-assisted tomography; ECLS, extracorporeal life support; ECMO, extracorporeal membrane oxygenation; PEA, pulseless electrical activity; ROSC, return of spontaneous circulation.

Declarations

Acknowledgements

The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.

Authors’ contributions

AL and TW created the concept, performed acquisition, analysis and interpretation of data and wrote the manuscript. HHO provided image content. FB, HHO and CB were involved in drafting the manuscript and revising it critically for important intellectual content. All authors gave final approval of the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report including clinical data and any accompanying images.

Ethics approval and consent to participate

No ethics approval was required in this case.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Heart Center, Department of Cardiology and Angiology I, University of Freiburg
(2)
Heart Center, Department of Cardiovascular Surgery, University of Freiburg
(3)
District Hospital Loerrach, Medical Clinic

References

  1. Meaney PA, Nadkarni VM, Kern KB, Indik JH, Halperin HR, Berg RA. Rhythms and outcomes of adult in-hospital cardiac arrest. Crit Care Med. 2010;38(1):101–8.View ArticlePubMedGoogle Scholar
  2. Wallmuller C, Meron G, Kurkciyan I, Schober A, Stratil P, Sterz F. Causes of in-hospital cardiac arrest and influence on outcome. Resuscitation. 2012;83(10):1206–11.View ArticlePubMedGoogle Scholar
  3. Soar J, Nolan JP, Bottiger BW, Perkins GD, Lott C, Carli P, Pellis T, Sandroni C, Skrifvars MB, Smith GB, et al. European resuscitation council guidelines for resuscitation 2015: section 3. Adult advanced life support. Resuscitation. 2015;95:100–47.View ArticlePubMedGoogle Scholar
  4. Desbiens NA. Simplifying the diagnosis and management of pulseless electrical activity in adults: a qualitative review. Crit Care Med. 2008;36(2):391–6.View ArticlePubMedGoogle Scholar
  5. Matsue Y, Suzuki M, Nishizaki M, Hojo R, Hashimoto Y, Sakurada H. Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. J Am Coll Cardiol. 2012;60(10):908–13.View ArticlePubMedGoogle Scholar
  6. Martin J, Sanfilippo F, Bradlow W, Sabharwal NK. Severe vasospastic angina complicated by multiple pulseless electrical activity arrests. Lancet. 2013;382(9890):478.View ArticlePubMedGoogle Scholar
  7. Gaikwad NJ, McNamara M, Batra R, Aroney G, Jayasinghe R. An unusual case of pulseless electrical activity arrest associated with Prinzmetal’s angina. Crit Care Resusc. 2010;12(4):269–72.PubMedGoogle Scholar
  8. Seniuk W, Mularek-Kubzdela T, Grygier M, Grajek S, Cieslinski A. Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study. J Intern Med. 2002;252(4):368–76.View ArticlePubMedGoogle Scholar
  9. Pober BR. Williams-Beuren syndrome. N Engl J Med. 2010;362(3):239–52.View ArticlePubMedGoogle Scholar
  10. Conrad SA, Grier LR, Scott LK, Green R, Jordan M. Percutaneous cannulation for extracorporeal membrane oxygenation by intensivists: a retrospective single-institution case series. Crit Care Med. 2015;43(5):1010–5.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement